ADAG Competitors & Alternatives
Compare Adagene Inc with similar stocks in the same industry
Biotechnology
ADAG
Main Stock$3.85
Tradestie Score
53
Market Cap
$94.26M
Revenue Growth
73.3%
Analyst Upside
+144.2%
Top Competitors
239 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$22.48
|
$297.23M | - | 58 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$35.27
|
$293.03M | - | 62 | Compare |
|
OMER
Omeros Corporation
|
$10.27
|
$281.75M | 9.1 | 57 | Compare |
|
DBVT
DBV Technologies S.A.
|
$16.08
|
$275.54M | - | 56 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$2.10
|
$275.13M | - | 58 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$19.75
|
$269.08M | - | 55 | Compare |
|
ZURA
Zura Bio Limited Class A Ordinary Shares
|
$5.51
|
$262.67M | - | 59 | Compare |
|
KYTX
Kyverna Therapeutics, Inc. Common Stock
|
$9.81
|
$258.18M | - | 59 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$42.84
|
$256.54M | - | 65 | Compare |
More ADAG Analysis
Data updated: Jul 09, 2026 | Industry: Biotechnology (SIC 2834)
239 stocks in this industry